Clinical Trial Update: 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 5-Fluorouracil combined with CoFactor (5,10-methylenetetrahydrofolate) in advanced breast cancer; trial status is currently un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CoFactor (5,10-methylenetetrahydrofolate)

Snippet

Sponsor: Mast Therapeutics, Inc. | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN